News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Vanhove Geertrui
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2022 |
4
| Vanhove Geertrui (Chief Medical Officer) has filed a Form 4 on Surrozen, Inc./DE|
Txns:
| Disposed/sold 24,587 options to buy
@ $10.77, valued at
$264.8k
Disposed/sold 10,427 options to buy
@ $10.25, valued at
$106.9k
Disposed/sold 26,220 options to buy
@ $10.25, valued at
$268.8k
Disposed/sold 1,760 options to buy
@ $10.77, valued at
$19k
Granted 26,220 options to buy
@ $2.16, valued at
$56.6k
Granted 10,427 options to buy
@ $2.16, valued at
$22.5k
Granted 24,587 options to buy
@ $2.16, valued at
$53.1k
Granted 1,760 options to buy
@ $2.16, valued at
$3.8k
|
|
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2021 |
3/A
| Vanhove Geertrui (Chief Medical Officer) has filed a Form 3/A on Surrozen, Inc./DE |
| 08/16/2021 |
4
| Vanhove Geertrui (Chief Medical Officer) has filed a Form 4 on Surrozen, Inc./DE|
Txns:
| Granted 36,647 options to buy
@ $10.25, valued at
$375.6k
|
|
| 08/16/2021 |
3
| Vanhove Geertrui (Chief Medical Officer) has filed a Form 3 on Surrozen, Inc./DE |
| 04/23/2019 |
4
| Vanhove Geertrui (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 8,083 shares
@ $0
Granted 24,000 options to buy
@ $5.96, valued at
$143k
Granted 20,935 options to buy
@ $6.36, valued at
$133.1k
|
|
| 04/23/2019 |
3
| Vanhove Geertrui (Director) has filed a Form 3 on Insys Therapeutics, Inc. |
| 04/19/2019 |
4
| Vanhove Geertrui (Director) has filed a Form 4 on Insys Therapeutics, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 8,083 shares
@ $0
Granted 24,000 options to buy
@ $5.96, valued at
$143k
Granted 20,935 options to buy
@ $6.36, valued at
$133.1k
|
|
| 04/19/2019 |
3
| Vanhove Geertrui (Director) has filed a Form 3 on Insys Therapeutics, Inc. |
|
|